View Author
resistance sequence subtype patient infection study mutation virus drug resistance analysis cypru strain number transmission population treatment prevalence level group model individual fluenza result table sample value country drug users disease therapy antiretroviral region university genotype phylogenetic signi response baseline score antibody 0.1 figure signi ficantly hepatitis europe effectiveness network hiv infection indinavir system migration reference impact parameter subtype b fi tness reduction change scenario genotypic epidemic incidence hospital tenofovir contact protease evolution method plasma virol landscape phylogenetic analysis range infettive malattie fication virological <0.0001 period position
10 Most Recent Publications
|
Cost-Effectiveness of Pre-Exposure Prophylaxis (PrEP) in Preventing HIV-1 Infections in Rural Zambia: A Modeling Study
(Article)
Nichols, B.E. Boucher, C.A.B. Dijk, F.J.H. van Thuma, P.E. Nouwen, J.L. Baltussen, R.M.P.M. Wijgert, J. van de Sloot, P.M.A. Vijver, D.A.M.C. van de |
2013-03-18
|
|
HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failure
(Article)
Sangeda, R.Z. Theys, K. Laethem, K. van Pironti, A. Zazzi, M. Sönnerborg, A. Incardona, F. Luca, A. de Torti, C. Ruiz, L. Vijver, D.A.M.C. van de Shafer, R.W. Beheydt, G. Bruzzone, B. Wijngaerden, E. van Vandamme, A.M. Rhee, S.Y. Deforche, K. Vercauteren, J. Libin, P. Imbrechts, S. Grossman, Z. Camacho, R.J. |
2013-01-01
|
|
Lipopolysaccharide levels are elevated in dengue virus infected patients and correlate with disease severity
(Article)
Weg, C.A.M. van de Koraka, P. Gorp, E.C.M. van Mairuhu, A.T.A. Supriatna, M. Soemantri, A. Vijver, D.A.M.C. van de Osterhaus, A.D.M.E. Martina, B.E.E. |
2012-01-01
|
|
Profiling of humoral immune responses to influenza viruses by using protein microarray
(Article)
Koopmans, M. Bruin, E. de Buisman, A. Beek, J. van Vijver, D.A.M.C. van de Reimerink, J.H.J. Godeke, G.-J. Friesema, I. Gageldonk, R. van Schipper, M. Meijer, A. Binnendijk, R.S. van Rimmelzwaan, G.F. Jong, M.D. de |
2011-12-26
|
|
Estimates of HIV transmitted drug resistance can be inflated due to natural sequence polymorphisms
(Article)
Frentz, D. Vijver, D.A.M.C. van de Boucher, C.A.B. Albert, J. |
2011-12-15
|
|
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study
(Article)
Prosperi, M.C.F. Mackie, N. Laethem, K. Bansi, L. Vijver, D.A.M.C. van de Geretti, A.M. Luca, A. de Giambenedetto, S. di Zazzi, M. Camacho, R. Fanti, I. Torti, C. Sönnerborg, A. Kaiser, R. Codoñer, F.M. |
2011-08-01
|
|
Baseline CD4+ T-cell counts and weighted background susceptibility scores strongly predict response to maraviroc regimens in treatment-experienced patients
(Article)
Schapiro, J.M. Boucher, C.A.B. Perros, M. Valdez, H. Van Der Ryst, E. Westby, M. Kuritzkes, D.R. Vijver, D.A.M.C. van de Llibre, J.M. Lewis, C.M. Simpson, P.M. Delogne, C. McFadyen, L. Chapman, D. |
2011-06-27
|
|
Increasing risk behaviour can outweigh the benefits of antiretroviral drug treatment on the HIV incidence among men-having-sex-with-men in Amsterdam
(Article)
Mei, S. Quax, R. Vijver, D.A.M.C. van de Zhu, Y. Sloot, P.M.A. |
2011-05-11
|
|
Quantitatively evaluating interventions in the influenza A (H1N1) epidemic on China campus grounded on individual-based simulations
(Article)
Mei, S. Vijver, D.A.M.C. van de Xuan, L. Zhu, Y. Sloot, P.M.A. |
2010-12-23
|
|
The risk of HIV drug resistance following implementation of pre-exposure prophylaxis
(Article)
Vijver, D.A.M.C. van de Boucher, C.A.B. |
2010-12-01
|
